Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07177638

A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.

This is a pilot study of a community- based melanoma educational intervention in Bensonhurst, Brooklyn conducted in-person by a community-health worker employed by the Perlmutter Cancer Center. Sample size will be around 35 participants. The participants will complete a pre-study survey and then take part in the educational session. There will be follow up study visits to assess the impact of the intervention on participant knowledge and skin self-examination behaviors at 3 weeks, 3 months, 6 months, and 12 months. At the 12-month mark, the participants will also complete a post-study survey.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Above 18 years of age
  • Individuals who understand and speak either English or Russian
  • Willingness and ability to consent and participate in the study

Exclusion criteria

  • Under 18 years of age
  • Individuals who do not understand and speak either English or Russian
  • Individuals who participated in the focus group portion of a related study.

Treatment and study plan

Education Sessions to Improve Melanoma Knowledge and Awareness

Behavioral

Community based educational seminar led by a community health worker with follow-up questionnaires to assess knowledge retention and behavioral change.

Primary outcomes

  1. Change in Melanoma Knowledge as Assessed by Questionnaire

    Time frame: Baseline, Immediately Post-Educational Session (Day 1)

    Melanoma knowledge/awareness will be assessed using a study questionnaire. Each item is multiple choice with 1 correct answer: the total score is the percentage of correct responses and ranges from 0-100%.

  2. Change in Melanoma Knowledge as Assessed by Questionnaire

    Time frame: Baseline, Week 3 Post-Intervention

    Melanoma knowledge/awareness will be assessed using a study questionnaire. Each item is multiple choice with 1 correct answer: the total score is the percentage of correct responses and ranges from 0-100%.

Secondary outcomes

  1. Change in Melanoma Knowledge as Assessed by Questionnaire

    Time frame: Month 3 Post-Intervention, Month 6 Post-Intervention

    Melanoma knowledge/awareness will be assessed using a study questionnaire. Each item is multiple choice with 1 correct answer: the total score is the percentage of correct responses and ranges from 0-100%.

  2. Change in Melanoma Knowledge as Assessed by Questionnaire

    Time frame: Month 3 Post-Intervention, Month 12 Post-Intervention

    Melanoma knowledge/awareness will be assessed using a study questionnaire. Each item is multiple choice with 1 correct answer: the total score is the percentage of correct responses and ranges from 0-100%.

  3. Change in Number of Self-Skin Examinations

    Time frame: Month 3 Post-Intervention, Month 6 Post-Intervention

    Assessed via survey.

  4. Change in Number of Self-Skin Examinations

    Time frame: Month 3 Post-Intervention, Month 12 Post-Intervention

    Assessed via survey.

Sponsors and collaborators

Lead sponsor

NYU Langone Health

Other

Registry information

Official study title

A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers: Pilot Proof of Concept Study

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 17, 2025
Registry last updated
Jul 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.